• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home / Covid Update

Covid-19 vaccine: Covaxin, Covishield production to be ramped up to a billion doses

Bharat Biotech and Serum Institute of India have announced plans to ramp up production

  • Money9
  • Last Updated : May 21, 2021, 17:09 IST
  • Follow
The Centre is now negotiating with Zydus on the price of the vaccine and will be decided in a meeting between the representatives of the company and the National Expert Group in Vaccine Administration for Covid (NEGVAC) headed by Niti Aayog member VK Paul and health ministry officials likely to be held this week. 
  • Follow

Hit by a devastating second wave of the Covid-19 infections, India has been focusing on ramping up domestic production of Covid-19 vaccines as well their procurement from abroad. Bharat Biotech and Serum Institute of India (SII), which are at the forefront of supplying Covid-19 vaccines in the country are doing their best to ramp up the production.

Covaxin Production Bharat Biotech has said that it plans to produce additional 200 million (20 crore) doses of Covid-19 vaccine ‘Covaxin’ at its subsidiary’s Gujarat-based facility, taking the overall production volume of the vaccine to about 1 billion (100 crore) dosages per annum.

The Hyderabad-based firm said it will utilise the Ankleshwar-based production facility of its wholly-owned subsidiary Chiron Behring Vaccines to add another 200 million doses of Covaxin. The Ankleshwar-based plant would start rolling out the much in demand vaccine from the fourth quarter of the year, it added. Bharat Biotech sells Covaxin to the states at Rs 400 per dose.

Covishield Production Reportedly, Serum Institute of India (SII) plans to increase its annual production capacity of Covishield from 1.5 to 2.5 billion doses per annum. Earlier this month, Adar Poonawalla CEO of SII, had asked the government for financial assistance to ramp up vaccine production. SII sells Covishield to states at Rs 400 per dose.

Raw material procurement Also, Indian foreign minister S Jaishankar will visit the United States from May 24 to 28 to press for further speeding up of the supply of raw materials to boost vaccine production in India besides exploring the option of joint production. Earlier this month, the US sent to India raw materials for vaccine production which it said would enable the manufacture of 20 million doses of the Covishield vaccines.

The US announced earlier this week that it will share an additional 20 million coronavirus vaccine doses with other countries in addition to the 60 million it has already committed.

Vaccination drive The cumulative number of COVID-19 vaccine doses administered in the country has surpassed 19 crore, the Union Health Ministry said on Thursday. On the day-125 of the vaccination drive on Thursday, a total of 14,56,088 vaccine doses — 12,73,785 first dose and 1,82,303 second dose — were given according to provisional report till 8 PM, the ministry data showed.

The ministry said of these 7,36,514 beneficiaries in the age group of 18-44 received their first dose on Thursday, and cumulatively the number reached 85,84,054 since the start of phase-3 of the vaccination drive on May 1.

Published: May 21, 2021, 17:06 IST

Download Money9 App for the latest updates on Personal Finance.

  • Covaxin
  • Covid-19
  • COVID-19 vaccine

Related

  • Covid first wave led to increase in antibiotic misuse in India: Study
  • Centre rushes teams to six states reporting a high number of Covid cases
  • Covid-19: India records 46,617 new cases; national recovery rate crosses 97%
  • India’s medical infrastructure well prepared to deal with possible third Covid wave, says FM
  • Karnataka makes RT-PCR negative report, vaccine certificate must for Kerala travellers
  • National Doctors’ Day: Over 1500 doctors sacrificed their lives in fight against Covid-19

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • DGCA प्रमुख ने सुचारू उड़ान संचालन सुनिश्चित करने के लिए पायलटों से मांगा सहयोग
  • रेपो दर में कटौती से घर के लिए कर्ज होगा सस्ता, मांग बढ़ेगी: रियल एस्टेट
  • मीशो के 5,421 करोड़ रुपये के आईपीओ को दूसरे दिन मिला 7.97 गुना अभिदान
  • इंडिगो को अगले साल 10 फरवरी तक उड़ान संचालन पूरी तरह बहाल होने की उम्मीद
  • Indigo की 200 से ज्यादा फ्लाइट रद्द, हजारों पैसेंजर फंसे
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close